The AMD Experts
We’re on a mission to eliminate blindness caused by age-related macular degeneration (AMD). Our vision is bold but well within reach.
MacuLogix® is a company that equips eye care professionals with the technology, tools, and education needed to help identify and manage AMD patients early, before irreversible vision loss has occurred. We can help you deliver better patient care with the scientifically validated AdaptDx Pro®.
Help us save the eyesight of millions by making early functional testing for AMD a routine part of eye care for your aging patients.
Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.
By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.
Latest News & Upcoming EventsView More
Getting to know your practice and what drives you to take great care of your patients, especially when it comes to AMD, is crucial. Christine Akers, Practice Management Consultant at MacuLogix, gives 4 steps for standardization for a successful AMD Program.
It’s an exciting time to be in eye care with so many new tools available and in the development pipeline. The AdaptDx Pro is a dark adaptomter that measures dark adaptation speed. This can be used to identify AMD with 90% sensitivity.
Your technician can operate the AdaptDx Pro in one language while selecting a different one for the patient to experience. Tailoring patient instructions to their native language can improve communication and trust.
Put Our Expertise to Work
Testing with AdaptDx Pro
AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.
Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.